HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kirstine N Bojsen-Møller Selected Research

Glucagon (Glukagon)

11/2022Four weeks treatment with the GLP-1 receptor analogue liraglutide lowers liver fat and concomitantly circulating glucagon in individuals with overweight.
1/2022On measurements of glucagon secretion in healthy, obese, and Roux-en-Y gastric bypass operated individuals using sandwich ELISA.
1/2019GLP-2 and GIP exert separate effects on bone turnover: A randomized, placebo-controlled, crossover study in healthy young men.
11/2017Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production.
9/2014Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?
5/2014Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass.
12/2013Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass.
9/2013Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kirstine N Bojsen-Møller Research Topics

Disease

17Insulin Resistance
04/2024 - 06/2013
15Type 2 Diabetes Mellitus (MODY)
11/2023 - 06/2013
13Weight Loss (Weight Reduction)
11/2023 - 09/2015
11Obesity
11/2023 - 07/2013
4Hyperinsulinism (Hyperinsulinemia)
04/2024 - 06/2013
4Body Weight (Weight, Body)
11/2022 - 05/2014
3Hypoglycemia (Reactive Hypoglycemia)
11/2023 - 01/2016
2Liver Diseases (Liver Disease)
04/2024 - 11/2023
2Heart Failure
11/2023 - 10/2022
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
04/2024
1Autoimmune Hepatitis
04/2024
1Sclerosing Cholangitis
04/2024
1Overweight
11/2022
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2022
1Cholelithiasis
01/2021
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
11/2020
1Bone Resorption
01/2019
1Inflammation (Inflammations)
12/2018
1Hyperglycemia
11/2017
1Glucose Intolerance
03/2015
1Chronic Kidney Failure (Chronic Renal Failure)
09/2014
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
07/2013

Drug/Important Bio-Agent (IBA)

20Glucose (Dextrose)FDA LinkGeneric
04/2024 - 06/2013
11Insulin (Novolin)FDA Link
04/2024 - 06/2013
9Glucagon-Like Peptide 1 (GLP 1)IBA
04/2024 - 09/2013
8Glucagon (Glukagon)FDA Link
11/2022 - 09/2013
6Proteins (Proteins, Gene)FDA Link
11/2023 - 09/2015
5Hormones (Hormone)IBA
11/2023 - 01/2018
4IncretinsIBA
04/2024 - 10/2019
3LiraglutideFDA Link
11/2023 - 01/2021
2Neprilysin (Neutral Endopeptidase)IBA
11/2023 - 10/2022
2FollistatinIBA
01/2023 - 01/2021
2Fatty Acids (Saturated Fatty Acids)IBA
01/2019 - 05/2014
2LipidsIBA
11/2018 - 07/2013
1Glucagon-Like Peptide-1 ReceptorIBA
11/2022
1Alanine (L-Alanine)FDA Link
11/2022
1Angiotensin Receptor AntagonistsIBA
10/2022
1sacubitril and valsartan sodium hydrate drug combinationIBA
10/2022
1Pancreatic HormonesIBA
10/2022
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2021
1activin AIBA
01/2021
1Peptides (Polypeptides)IBA
01/2019
1Collagen Type I (Type I Collagen)IBA
01/2019
1ProcollagenIBA
01/2019
1Amino AcidsFDA Link
01/2019
1Peptide YYIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2017
1AdiponectinIBA
09/2015
1C-PeptideIBA
06/2013

Therapy/Procedure

21Gastric Bypass (Roux-en-Y Gastric Bypass)
11/2023 - 06/2013
4Bariatric Surgery
11/2023 - 01/2018
4Glycemic Control
01/2021 - 05/2014
2Therapeutics
11/2023 - 01/2021
2Gastrectomy
01/2021 - 01/2019
1Drug Therapy (Chemotherapy)
11/2023
1Caloric Restriction
01/2021
1Operative Surgical Procedures
01/2019
1Vagotomy
09/2014